What is the recommended prevention and treatment protocol for osteopenia of prematurity in infants born before 32 weeks gestation or weighing less than 1500 g?

Osteopenia of Prematurity: Prevention and Treatment Protocol

For infants born <32 weeks gestation or <1500g, implement early aggressive calcium and phosphorus supplementation starting in the first week of life, combined with vitamin D 400 IU/day, to prevent osteopenia of prematurity.

Risk Stratification

Infants at highest risk include 1:

• Birth weight <1500g or gestational age <28 weeks
• Prolonged total parenteral nutrition (≥4 weeks)
• Bronchopulmonary dysplasia
• Prolonged diuretic or corticosteroid therapy
• Small for gestational age status 2

Prevention Protocol

Early Parenteral Nutrition Phase (First Days of Life)

During initial stabilization, use lower mineral intakes with a molar Ca:P ratio of 0.8-1.0 to prevent early hypercalcemia and hypophosphataemia 3:

• Calcium: 0.8-2.0 mmol/kg/day (32-80 mg/kg/day)
• Phosphorus: 1.0-2.0 mmol/kg/day (31-62 mg/kg/day)
• Magnesium: 0.1-0.2 mmol/kg/day (2.5-5.0 mg/kg/day)

Growing Preterm Infant Phase

Once stable and growing, increase to aggressive supplementation 3:

• Calcium: 1.6-3.5 mmol/kg/day (64-140 mg/kg/day)
• Phosphorus: 1.6-3.5 mmol/kg/day (50-108 mg/kg/day)
• Magnesium: 0.2-0.3 mmol/kg/day (5.0-7.5 mg/kg/day)

Continuous high-dose calcium with organic phosphate salts is particularly beneficial 4. The most recent meta-analysis demonstrates that nutritional prophylaxis reduces MBDP incidence by 54%, with early calcium/phosphorus supplementation achieving 74-84% risk reduction 5.

Vitamin D Supplementation

• Standard dose: 400 IU/day is sufficient for prevention 6
• Higher doses (>400 IU/day) offer no additional benefit 4
• Begin supplementation early in at-risk neonates 7

Critical caveat: Low-dose vitamin D (200 IU/day) may be adequate, but 400 IU/day provides a safety margin without toxicity risk 6.

Monitoring Protocol

Biochemical Surveillance

Monitor every 2 weeks during NICU stay 7:

• Serum calcium, phosphorus, alkaline phosphatase
• Parathyroid hormone at 2 and 8 weeks
• 25-hydroxyvitamin D at birth and 8 weeks

Key diagnostic thresholds:

• Alkaline phosphatase >500 IU/L indicates osteopenia 8
• Hypophosphatemia (P <1.6 mmol/L) at 2 weeks is an early warning sign 7
• Elevated PTH at 8 weeks correlates with low vitamin D 7

Urinary Monitoring

Check urine calcium and phosphorus concentrations 3:

• Target: Both minerals excreted simultaneously with concentrations >1 mmol/L
• This indicates slight surplus and adequate intake

Radiological Assessment

Wrist radiographs at 6-8 weeks if biochemical abnormalities present 6. DEXA scanning is more sensitive than ultrasound when available 9.

Treatment of Established Osteopenia

When biochemical evidence of osteopenia appears (typically 6-12 weeks of life) 1:

1. Increase phosphorus supplementation - begin in second week of life if indicated 7
2. Maintain vitamin D at 1320 IU/daily (therapeutic dose) 7
3. Optimize calcium intake to match increased phosphorus
4. Add physiotherapy/mechanical interventions - improves bone mineral content by 28% and quantitative ultrasound speed-of-sound by 75.3 m/s 5

Adjunctive Mechanical Interventions

Active or reflex-based physiotherapy improves bone density and growth 4. The most recent systematic review confirms mechanical interventions effectively improve bone mineralization with favorable safety profiles 5. However, passive approaches show limited effect 4.

Special Considerations

Maternal Magnesium Exposure

Adapt magnesium intakes based on postnatal blood concentrations in infants exposed to maternal magnesium therapy 3.

Intrauterine Growth Restriction

These infants require careful monitoring of plasma phosphate within first days of life to prevent severe hypophosphataemia that can cause muscle weakness, respiratory failure, cardiac dysfunction, and death 3.

Long-term Monitoring

For infants on prolonged parenteral nutrition, periodic monitoring of calcium, phosphorus, vitamin D, and bone mineral status is required to assess metabolic bone disease risk 3.

Prognosis

Osteopenia of prematurity typically presents between 6-12 weeks of life 1. Fractures usually occur in the first year of life, with rib fractures found incidentally and long bone fractures presenting with extremity swelling 1. After the first year of life, bone density normalizes 1, and catch-up mineralization occurs rapidly during the post-term period 9. However, long-term consequences on peak bone mass attainment remain uncertain 9.

Important pitfall: Although osteopenia makes infants more vulnerable to fractures, preterm infants are also at increased risk of abuse - do not automatically attribute all fractures to osteopenia 1.